We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 187.50
Bid: 180.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 15.00 (8.333%)
Open: 187.50
High: 187.50
Low: 187.50
Prev. Close: 187.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

13 Dec 2019 12:00

RNS Number : 8258W
Synectics PLC
13 December 2019
 

 

 

 

 

13 December 2019

 

 

Synectics plc

('Synectics' or the 'Company')

 

Directorate Change

Synectics plc (AIM: SNX), a leader in the design, integration, control and management of advanced surveillance technology and networked security systems, is pleased to announce that it has appointed David Bedford as Finance Director with effect from 6 January 2020.

Mr Bedford will lead the Company’s Finance and Administration functions from its Registered Office in Sheffield, which recently relocated from Studley, Warwickshire. A period of overlap will allow for a handover of responsibilities with the current Warwickshire-based team, led by acting Finance Director Amanda Larnder, remaining in place until April 2020.

David holds a degree in Economics & Accounting from the University of Bristol and is a member of the Institute of Chartered Accountants in England and Wales. He brings extensive UK and international finance leadership experience gained within a range of well-respected organisations.

Having qualified with Deloitte & Touche in 1994, David joined Price Waterhouse’s corporate finance group. Over the last 15 years, David has held a number of senior finance positions within IMI Precision, the largest division of IMI Plc, the FTSE-250 specialist engineering group. During his time at IMI, David helped drive profitable growth as Regional Finance Director for businesses in Europe, the US and Asia. Most recently, he served in a global role as Commercial Finance Director, supporting major new product launches, working on acquisitions and helping drive the organisation’s digital transformation. Prior to joining IMI, David spent 7 years with Jaguar Land Rover.

 

David Coghlan, Chairman of Synectics, commented: "I am delighted with David's appointment as Synectics' Finance Director. His skills and experience will strengthen Synectics' senior leadership team and we look forward to working closely with him."

 

 

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

David Coghlan, Chairman

www.synecticsplc.com

email: david.coghlan@synecticsplc.com

Paul Webb, Chief Executive

Email: paul.webb@synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks

 

 

 

 

 

Appendix - AIM Rule 17

 

There are no disclosures to be made in accordance with Rule 17, Schedule Two (g) of the AIM Rules for Companies in respect of the appointment of David Michael Bedford, aged 51. Mr Bedford does not hold an interest in the Company's share capital.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUOORRKBAUAAA
Date   Source Headline
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares
22nd Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
13th Feb 20237:00 amRNSNotice of Results
13th Dec 20227:00 amRNSTrading Update
1st Dec 20227:00 amRNSCompletion of sale of non-core Business
11th Nov 20227:00 amRNSSale of non-core Business
7th Nov 20227:00 amRNSDirectorate Change
24th Oct 20227:00 amRNSBoard Change and Update on Chairman Recruitment
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSDirector’s and PDMRs' Interests in Share Schemes
12th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:00 pmRNSInvestor Presentation
5th Jul 20227:00 amRNSDirectorate Change
22nd Jun 20227:00 amRNSProposed Board Change
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding
20th Apr 202212:05 pmRNSResult of AGM
20th Apr 20227:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.